Advanced Medical Technology
Blood Irradiation (BI)works by triggering a photochemical reaction that cleans and revitalizes the blood, accelerating the healing process within the entire body. The device systems and methods used to execute treatment can be very different. There are two common wavelengths of light primary used, UV and red, each responsible for different biochemical actions. Both wavelengths have a positive systemic effect on the body.
In his 2003 book, Close-to-Nature Medicine, Kenneth Dillon, Ph.D. clearly points out the overwhelming data proving light has the ability to destroy pathogens in the blood. “Human beings have a chemiluminescent immune system,” he said. He also points out blood irradiation is accomplished by utilizing the body’s own natural defenses to recognize and annihilate the sick, diseased cells. Dillon said, “It is very shocking that, after 20 years of a devastating epidemic…the medical establishment has still failed to test this excellent therapy.”
How much control do humans really have over stopping a global pandemic outbreak? The United States considers resistant infection a “very high priority,” and so has created a coalition to eliminate the possible threat. The coalition is composed of the Center for Disease Control (CDC), Active Bacterial Core surveillance (ABCs), Emerging Infections Programs (EIP), Transatlantic Task Force on Antibiotic Resistance (TATFAR) and Infectious Diseases Society of America (IDSA)
The current belief is that there is no way to deal with a catastrophe of that scale. Multi drug-resistant bacteria have been around for decades. Bacteria are equipped with a gene enabling them to produce an enzyme that disables antibiotics, rendering the drugs powerless.
The World Health Organization (WHO) has recommended countries around the world pay serious attention to the emergence of this resistance factor. The Handbook of Biosurveillance, published in 2006, outlines principles that apply to both natural and man-made biowar epidemics. Bioterrorism is the intentional release or dissemination of biological agents into the environment to cause illness or death in people, animals, or plants. They include the use of germ bacterium, viruses, prions, fungal agents and biological toxins
As disease resistance continues with current medications, and biowar threats loom in the distance, the need for reliable and effective alternative treatments becomes even greater. The use of light based medical technology may be the only viable solution as harmful bacterial and viral cells contain up to five times more photosensitive amino acids, making them extremely susceptible to destruction by light.
Blood irradiation using UV light is most commonly called ultraviolet blood irradiation (UBI). This treatment removes a small amount blood from the patient, exposes it to light then returns the blood back to the patient intravenously. This system is quite effective at removing harmful substances and is proven effective in:
• inactivating pathogens and contaminants
• destroying viruses
• eliminating bacteria
• inactivating toxins
• inactivating snake venom
• activating white blood cells
• helping blood viscosity acting as a blood thinner
• increasing blood oxygen transport
• decreasing platelet aggregation
• removing of fungi and parasites
• inactivating e-coli
• causing diphtheria to become unstable
• causing tetanus to become unstable
• helping vascular conditions and circulatory activities, improving circulation
• reducing arterial plaque
• decreasing swelling
• stabilizing alkalinity
• increasing intracellular antioxidants that buffer and neutralize free radicals
• balancing calcium and phosphorous
• accelerating the lymphatic system
• stimulating antibody production
• immunizing the body against disease
• activating steroid hormones
• producing a positive effect on the autonomic nervous system
• stimulating corticosteroid production
• helping to reduce nausea and vomiting
• reducing symptoms of candida
• reduces symptoms of chronic fatigue
• reducing symptoms of allergies
• reducing symptoms of emphysema
• reducing diabetic complications
• reducing symptoms of rheumatologic diseases
• helping to eliminate acute colds
• helping to eliminate flu
• reducing symptoms of fibromyalgia
• assisting in recovery of stroke
• reducing symptoms of bronchitis
• reducing chemical sensitivity
• helping reduce problem relating to arterial disease
• reducing symptoms of macular degeneration
Blood Irradiation with light is a treatment system that has been reinvented several times throughout modern medical history, first by the Danish, then the Americans and more recently, the Russians. Strangely however, it has never taken hold, even with all its remarkable results. Blood Irradiation is known by many terms including:
• extracorporeal photopheresis
• ultraviolet blood irradiation (UBI)
• intravenous laser blood irradiation (ILBI)
• blood photomodifcation
• trans-dermal blood irradiation (TDBI)
• sublingual blood irradiation
• extracorporeal photochemotherapy
• photoluminescence therapy
• biophotonic therapy
• photobiological therapy
• hemo-irradiation phototherapy
• hematologic oxidative therapy
• ultraviolet hemo-irradiation phototherapy
An excerpt from the American Cancer Society’s website reads, “A special form of UV blood irradiation called photopheresis…also inhibits T-cell lymphoma and may be helpful for other conditions. Proponents of UV blood irradiation claim UV…kills germs…inside the body and…neutralizes toxins in the blood. Some claim even a small amount of UV treated blood can reenter the circulatory system of the patient and stimulate the immune system…against invaders, including cancer cells.” Ultraviolet blood irradiation treatment is approved by the FDA for treating T-cell lymphoma. Some clinical trial results look promising for the treatment of immune system diseases such as: 
• multiple sclerosis
• systemic sclerosis
• rheumatoid arthritis
• type 1 diabetes
BI treatments have advanced since they were first developed. In some cases people are injected with light sensitive compounds prior to light exposure. There are other systems that remove the blood and then mix it with compounds followed by exposure to light. In other scenarios, hydrogen peroxide is mixed into the blood as it circulates, to increase oxygen in the blood. Here are a few methods to conduct this process:
• intravenously, wherein the blood is circulated for exposure in a closed loop system
• blood is drawn, put into a irradiation device, and then re-injected
• laser inside a needle inserted directly into vein
• trans-dermal, a high powered LED or low wattage laser is placed onto skin on specific location
• sublingually, placing the light under the tongue
In standard BI treatment, a patient is taken through the following process: The amount of blood irradiated during the treatment depends upon a patient’s body weight. This is based upon a ratio of approximately 1/16th of the patient’s blood. In some cases an anticoagulant such as Heparin is added to prevent the blood from clotting. The treatment begins when a needle is placed into the arm which is connected to a UV recirculation system. The patient’s blood is drawn and then placed into a device where the syringe rotates slowly for a few minutes, exposing the blood to UV light. The irradiated blood is then injected back into the patient.
Sessions for either photobiological treatment take about an hour and can be done two to three times per week for several weeks, depending upon the severity of the disease. In the most severe cases, patients can receive treatment as often as once every twenty-four hours; less severe cases require fewer treatments.
In Denmark at the beginning twentieth century, Finsen developed a quasi-UV light system using a prism. As a victim of Pick’s Disease, he noticed spending time in the sun alleviated some of his conditions such as anemia and fatigue. When available literature could not help him explain the change, he began researching the lights’ power. Soon after, Walter Ude reported success in treating several cases of acute streptococcal infection by irradiating the skin with UV light, emulating Finsen’s innovations.
Then in 1928 Emmit S. Knott developed equipment to perform the BI process intravenously. Knott pioneered blood irradiation on dogs before treating humans. His first patient suffered from a bacterial blood infection (sepsis), but recovered rapidly after the treatment. Knott, while working with Dr. Virgil Hancock, had great results and published their findings in 1934. By 1942 they had treated over 6,500 patients. During that era, Dr. George Miley, a clinical professor at Hahnemann Hospital and College of Medicine in Philadelphia, reported 151 consecutive cases with astounding results when patients were treated with UBI. Miley, however, noted a decrease in blood oxygen in many diseased states. The body consumes approximately 100 times more oxygen when it is responding to infection. Miley said there was a “pinking-up” of the patient’s skin after treatment and a rise in blood oxygen levels without a rise in hemoglobin or red-cell count. In moderately advanced cases, ninety-eight percent recovered. Miley treated a woman who had slipped into a coma from an almost certainly fatal infection brought on by botulism. Within seventy-two hours of her first UBI treatment, the woman was awake and mentally clear and was discharged thirteen days later.
Much American medical literature during the 1930s and early 1940s reported cases where dying patients responded to UBI treatment almost instantaneously, some within hours. In his 1943 book, Ultraviolet Blood Irradiation, Miley published the successful results of treating many diseases, including viral pneumonia. He noted that a complete disappearance of major symptoms occurred within twenty-four to seventy-two hours after a single UBI treatment. Coughing eased in three to seven days, and lungs cleared in one to four days. There is currently no other photobiological treatment available that can produce such results.
In 1967 Robert Olney published material entitled Blocked Oxidation in which he pointed out cancer was a result of blocked oxidation within cells. The data presented five cases of various cancers that were cured by a combination of techniques including UBI. Olney also treated individuals with hepatitis using UV light, documenting a study of forty-three patients. An average number of three treatments were conducted: twenty-seven patients showed rapid subsidence of symptoms, eleven showed marked improvement in four to seven days, and five showed improvement in eight to fourteen days. Dr. William Douglass has written several articles and books on health and medicine, and continues to uncover truths, while debunking deceptions within the medical community. He examines case studies and the mechanisms behind UBI and it near-miraculous results in his book, Into the Light-Tomorrow’s Medicine Today. 
While most doctors focus on treating diseases, some like Len Saputo focus on wellness. Another proponent of wellness philosophy is Francisco Contreras, M.D. He examines patients holistically and analyzes all systemic and environmental factors. In his approach to medicine (conventional-alternative) he augments the best of both worlds. People from all over the world seek treatment at his Oasis of Hope Hospitals in California and Mexico.
There is a clear need to integrate this therapy into cancer treatment regimens, as they do not compromise the immune system or health of the patients. Contreras mentions how effective UBI is in the treatment of hepatitis and pneumonia in his book, Dismantling Cancer. Some treatments include MOP-8. UV light destroys bacterial and viral pathogens and once the treated blood is back in the body, those dead pathogens produce a systemic “vaccination” effect and also act as antitumor agents. Additionally, the blood returned to the body continues to kill bacteria, viruses and toxins, and creates more white blood cells to resolve any systemic problems. How this mechanism works is not clearly understood, but according to Contreras, the blood holds radiation from its exposure to UV rays, and once back in the body, stimulates additional biochemical and photobiological reactions.
Incorporating light-activating agents such as MOP-8 increase the photobiological effect. Dr. Richard Edelson of Yale University developed a technique called UV extracorporeal photophoresis. The treatment requires separation of the white blood cells, which means UV light does not irradiate all of the blood. Unfortunately, there are many elements other than white blood cells that are photosensitive including:
• amino acids
Some believe these elements should also be exposed to the light. In Edelson’s technique the patient receives MOP-8 two hours before the blood is withdrawn. This therapy has proven successful and received FDA approval for the treatment of lymphoma; however, it costs several times more than traditional BI treatment.
Another innovative method of treatment is a non-invasive system called sublingual UV photoluminescent therapy where a device is placed under the tongue and the patient is irradiated with UV light for approximately an hour. This particular placement is effective since a tremendous amount of blood travels through the tongue. Thomas Perez, President of Harris Medical Resources,developed and successfully tested this new UBI treatment. His team in Africa obtained impressive preliminary test results on twenty people infected with HIV. The largest expense during the clinical trials was the viral load tests. The cost of operating the light device is minimal. The patients received approximately forty one-hour treatments. A few patients felt so good afterwards that they left the study believing they were cured. Later, the majority of people were once again tested to determine viral load counts. According to Perez, there was no detectable level of HIV in the patient’s blood. This does not mean that the virus was completely gone, but it definitely was not in their blood, which is significant, because if the virus is not present, it cannot create symptoms.
There are few companies marketing UBI products. Longevity Resources Inc., a Canadian based company, calls their unit the Aquatron UV, manufactured in Germany. Touting it as reliable and extremely easy to use, this UV light is at a precise wavelength of 254nm. The practitioner buys sterile, single use disposable cuvettes made of high quality quartz glass. The duel UVC or UVA devices are double sided exposure systems. Another system marketed by Lumen Associates, a Canadian company, uses disposable materials to reduce costs and improve safety. President Doug Kemp believes his new system will provide quick, effective treatment and at a lower cost, compared to traditional UBI treatment. It treats blood via a syringe, in which it is drawn and exposed to UV light and then returned to the patient, thus eliminating the cuvette.
Other astounding results in the field of medical light are coming from Russian scientists and doctors. Years ago, the Russian medical system was funded by the former USSR government, so it was in their best interest to heal people quickly and inexpensively. This model forced innovations in health technology. The Russians developed a different clinical process of BI or blood photomodification. They expanded the scope of BI by using lasers intravenously, calling it “intravenous laser blood irradiation” (ILBI). It was determined that the light’s primary absorption point is the porphyrin (light sensitive) molecule, which creates a physicochemical chain reaction and activates an antioxidant defense system, which in turn, revitalizes the circulating cell population of neutrophils and makes them more resistant.
Great results have been reported by doctors; but, “the mechanism of it is not clear, yet scientists believe it is some sort of immune modulation,” said Dr. Karu. When blood is irradiated during surgery, the blood becomes brighter, more oxygenated, and its viscosity lowers, becoming thinner and thus enabling better circulation. BI has been effective in treating coronary diseases but seems to help with most conditions. This inner-vascular system uses a quartz fiber optic cable that gets inserted into a vein through a 10 millimeter needle, and then illuminating a 633nm red laser.
Light therapy has found a prominent position at the State University Medical Center in Georgia, Russia where basic methods of treatment are intravenous laser blood irradiation (ILBI) and non-invasive trans-dermal blood irradiation (TDBI). Studies were conducted to determine the efficacy of non-medicated treatment. In one study, people suffering from poor circulation were treated seven to ten times daily with ILBI. The researchers found normalization in microcirculation disturbances. In another study with pregnant women, the main objective was to avoid adverse side effects of medication and minimize any pharmacological impact on the developing fetus. The study was comprehensive, outlining BI treatment for various indications including:
• disturbances in fetal growth
• labor induction
• chronic urogenital infections
• herpes-virus infection
It was concluded that BI’s “potentialities in the gynecological practice are limitless.” It was also found that ILBI therapy averted patients from surgery, required fewer anesthetics and narcotic analgesics following treatment and achieved greater stability and homeostasis (overall health). ILBI also improved blood oxygen levels and normalized heart rhythm. Gastro-intestinal studies were also promising. It was clear that ILBI caused a positive photobiological effect, as there was a corrective influence on pre-cancerous changes in the mucus membrane of the stomach. In cases where patients had cardiovascular and organ infections, IBLI was also effective.
The reports said the biostimulatory effects of the laser consist of activating the bio-energetic processes of an organism. The Russians reported the following clinical changes:
• increased proliferation activity of human bone marrow cells
• stimulation of DNA
• activated chromosome repair
• fibroblast growth factors (synthesizes collagen, critical in wound healing)
• lymphocyte proliferation (natural killer cells)
• monocytes proliferation (inflammatory responders, immune system)
• granulocytes proliferation (white blood cells)
• blood becomes alkaline, stabilizing pH balance
• resistant neutrophils with enhanced function (first-responders to inflammation)
• stimulation of tissue regeneration
• pathology detoxification effect (ridding of disease)
• thrombolytic action (breaking down of blood clots)
• increased cells’ resistance to pathogenic agents (cell stronger against disease)
• stimulation of general and local factors of immune protection
• decreases pathogenicity of microbes and growth of their sensitivity to antibiotics
• normalization of liquid metabolism
• conformational transformation in proteins
• changes in physical and chemical properties of bioliquids
• transportation and membranes properties of organelles and cells
• changes in activity in biochemical reactions
Though discovered years ago, these blood irradiation systems are still in their infancy. Out of all the technologies presented herein, this technology promises to have the greatest impact on the health care systems worldwide.
Both antibiotics and BI were discovered around the same time. It was 1928 when Alexander Fleming came across penicillin in his lab. Antibiotics presented a streamlined approach to medicine; once mass produced, they could be easily transported around the world. Irradiation of a patients’ blood, however, had to be conducted with a special device and industrial technology did not have the means or wherewithal for large scale treatments back then. Thus, the use of light in blood irradiation faded into obscurity and did not resurface until recently.
Now, new advances in photobiological technology offer BI the opportunity to take its rightful place in health care. The question is, how long will we have to wait? Perhaps if health care consumers voice their opinions, the medical system will be forced to adapt such innovations.
Copyright © Matt DeBow
Broadcast Permission Granted
It is permissible to post this information on the internet under the condition that web address information remain with top and bottom page with active links.